Rifamycins

Known as: Rifamycin, Rifamycins [Chemical/Ingredient], 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-B)furan-1,11(2h)-dione 21-Acetate 
A natural antibiotic produced by Streptomyces mediterranei, Rifamycin (Ansamycin Family) is a commonly used antimycobacterial drug that inhibits… (More)
National Institutes of Health

Related topics

Related topics

46 relations

Narrower (35)

27-O-demethylrifamycin S3-hydrazinorifamycinABI 0043ABI 1131
(More)

Broader (3)

Anti-Bacterial AgentsAntibioticsNaphthols
In BloodRifampinagonistsantagonists & inhibitors
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Occurrence and characteristics of extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae in food producing animals, minced meat and raw milk
BACKGROUND The impact of food animals as a possible reservoir for extended-spectrum beta-lactamase (ESBL) producing… (More)
  • table 1
  • table 2
  • table 2
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
DNA sequence analysis of the genetic environment of various blaCTX-M genes.
OBJECTIVES Over a 3 year period (2000-2003) 21 Escherichia coli, 5 Klebsiella pneumoniae, 1 Serratia marcescens and 1 Proteus… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
BACKGROUND The occurrence of acquired rifamycin resistance despite use of directly observed therapy for tuberculosis is… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.
The occurrence of extended-spectrum beta-lactamase (ESBL)-producing isolates has increased worldwide. Fecal carriage of ESBL… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France.
We analyzed 19 clinical isolates of the family Enterobacteriaceae (16 Escherichia coli isolates and 3 Klebsiella pneumoniae… (More)
  • table 1
  • table 2
  • table 4
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals.
Nine clinical isolates of Enterobacteriaceae (six Escherichia coli and three Proteus mirabilis) isolated in three Parisian… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Review
2001
Review
2001
Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.
The rifamycin antibacterials, rifampicin (rifampin), rifabutin and rifapentine, are uniquely potent in the treatment of patients… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid
BACKGROUND Rifapentine is a cyclopentyl-substituted rifamycin whose serum half-life is five times that of rifampin. The US Public… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.
The contributions of 23 insertion, deletion, or missense mutations within an 81-bp fragment of rpoB, the gene encoding the beta… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Review
1971
Review
1971
Actions of the rifamycins.
INTRODUCTION............................................................ 290 ACTION ON BACTERIA… (More)
  • table 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?